Population Structure of Invasive Streptococcus pneumoniae in the Netherlands Before Vaccination
Author Information
Author(s): Elberse Karin E. M., van de Pol Ingrid, Witteveen Sandra, van der Heide Han G. J., Schot Corrie S., van Dijk Anita, van der Ende Arie, Schouls Leo M.
Primary Institution: National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Hypothesis
The introduction of nationwide pneumococcal vaccination may lead to serotype replacement and the emergence of new variants.
Conclusion
MLVA and CST are effective tools for monitoring the population structure of pneumococcal isolates and the effects of vaccination.
Supporting Evidence
- 1154 clinical isolates were analyzed to assess the population structure of Streptococcus pneumoniae.
- MLVA showed high genetic diversity among some serotypes while others were more homogeneous.
- CST successfully discriminated most serotypes present in the collection.
Takeaway
Scientists studied bacteria that cause pneumonia in the Netherlands before a vaccine was introduced to see how they were different.
Methodology
The study used Capsular Sequence Typing (CST) and Multiple-Locus Variable number tandem repeat Analysis (MLVA) to analyze 1154 clinical isolates.
Limitations
The study only represents the pneumococcal population before vaccination and may not reflect post-vaccination changes.
Participant Demographics
Isolates were collected from patients with invasive pneumococcal disease, including children and adults.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website